Nuveen Asset Management, LLC Viking Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 319,868 shares of VKTX stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
319,868
Previous 318,000
0.59%
Holding current value
$10.7 Million
Previous $20.1 Million
36.07%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding VKTX
# of Institutions
456Shares Held
68.1MCall Options Held
7.72MPut Options Held
3.31M-
Vanguard Group Inc Valley Forge, PA10.2MShares$341 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$202 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$127 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$109 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$105 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.57B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...